Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs.

Edelman EJ, Moore BA, Calabrese SK, Berkenblit G, Cunningham C, Patel V, Phillips K, Tetrault JM, Shah M, Fiellin DA, Blackstock O.

AIDS Behav. 2017 Apr;21(4):1025-1033. doi: 10.1007/s10461-016-1612-6.

PMID:
27896552
2.

PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa.

McGillen JB, Anderson SJ, Hallett TB.

J Int AIDS Soc. 2016 Oct 18;19(7(Suppl 6)):21104. doi: 10.7448/IAS.19.7.21104. eCollection 2016.

3.

Critical Review: When the Party is Over: A Systematic Review of Behavioral Interventions for Substance-Using Men Who Have Sex with Men.

Carrico AW, Zepf R, Meanley S, Batchelder A, Stall R.

J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):299-306. Review.

PMID:
27258233
4.

To Use a Rectal Microbicide, First Insert the Applicator: Gel and Applicator Satisfaction Among Young Men Who Have Sex With Men.

Bauermeister J, Giguere R, Dolezal C, Leu CS, Febo I, Cranston RD, Mayer K, McGowan I, Carballo-DiƩguez A.

AIDS Educ Prev. 2016 Feb;28(1):1-10. doi: 10.1521/aeap.2016.28.1.1.

5.
6.

Passing the baton: Community-based ethnography to design a randomized clinical trial on the effectiveness of oral pre-exposure prophylaxis for HIV prevention among Black men who have sex with men.

Garcia J, Colson PW, Parker C, Hirsch JS.

Contemp Clin Trials. 2015 Nov;45(Pt B):244-251. doi: 10.1016/j.cct.2015.10.005. Epub 2015 Nov 9.

7.

A Clinical Home for Preexposure Prophylaxis: Diverse Health Care Providers' Perspectives on the "Purview Paradox".

Hoffman S, Guidry JA, Collier KL, Mantell JE, Boccher-Lattimore D, Kaighobadi F, Sandfort TG.

J Int Assoc Provid AIDS Care. 2016 Jan-Feb;15(1):59-65. doi: 10.1177/2325957415600798. Epub 2015 Aug 20.

8.

Narrative review of models and success factors for scaling up public health interventions.

Milat AJ, Bauman A, Redman S.

Implement Sci. 2015 Aug 12;10:113. doi: 10.1186/s13012-015-0301-6. Review.

9.

Motivations for Reducing Other HIV Risk-Reduction Practices if Taking Pre-Exposure Prophylaxis: Findings from a Qualitative Study Among Women in Kenya and South Africa.

Corneli A, Namey E, Ahmed K, Agot K, Skhosana J, Odhiambo J, Guest G.

AIDS Patient Care STDS. 2015 Sep;29(9):503-9. doi: 10.1089/apc.2015.0038. Epub 2015 Jul 21.

10.

Beyond informed consent: ethical considerations in the design and implementation of sexual and reproductive health research among adolescents.

Folayan MO, Haire B, Harrison A, Fatusi O, Brown B.

Afr J Reprod Health. 2014 Sep;18(3 Spec No):118-26.

11.

The current status of the use of oral medication to prevent HIV transmission.

Mayer KH, Ramjee G.

Curr Opin HIV AIDS. 2015 Jul;10(4):226-32. doi: 10.1097/COH.0000000000000170. Review.

12.

"Why should I take drugs for your infection?": outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria.

Idoko J, Folayan MO, Dadem NY, Kolawole GO, Anenih J, Alhassan E.

BMC Public Health. 2015 Apr 10;15:349. doi: 10.1186/s12889-015-1690-9.

13.

Combination HIV prevention interventions: the potential of integrated behavioral and biomedical approaches.

Brown JL, Sales JM, DiClemente RJ.

Curr HIV/AIDS Rep. 2014 Dec;11(4):363-75. doi: 10.1007/s11904-014-0228-6. Review.

14.

Pre-exposure prophylaxis of HIV: A right way to go or a long way to go?

Yu W, Wang L, Han N, Zhang X, Mahapatra T, Mahapatra S, Babu GR, Tang W, Detels R, Zhao J.

Artif Cells Nanomed Biotechnol. 2016;44(1):201-8. doi: 10.3109/21691401.2014.934458. Epub 2014 Jul 31. Review.

15.

Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges.

McMahon JM, Myers JE, Kurth AE, Cohen SE, Mannheimer SB, Simmons J, Pouget ER, Trabold N, Haberer JE.

AIDS Patient Care STDS. 2014 Sep;28(9):462-74. doi: 10.1089/apc.2013.0302. Epub 2014 Jul 21. Review.

17.

Silencing sexually transmitted infections: topical siRNA-based interventions for the prevention of HIV and HSV.

Wheeler LA.

Infect Dis Obstet Gynecol. 2014;2014:125087. doi: 10.1155/2014/125087. Epub 2014 Jan 12. Review.

18.

Sexual risk trajectories among MSM in the United States: implications for pre-exposure prophylaxis delivery.

Pines HA, Gorbach PM, Weiss RE, Shoptaw S, Landovitz RJ, Javanbakht M, Ostrow DG, Stall RD, Plankey M.

J Acquir Immune Defic Syndr. 2014 Apr 15;65(5):579-86. doi: 10.1097/QAI.0000000000000101.

19.

The impact of patient race on clinical decisions related to prescribing HIV pre-exposure prophylaxis (PrEP): assumptions about sexual risk compensation and implications for access.

Calabrese SK, Earnshaw VA, Underhill K, Hansen NB, Dovidio JF.

AIDS Behav. 2014 Feb;18(2):226-40. doi: 10.1007/s10461-013-0675-x.

20.

Integrating Behavioral HIV Interventions into Biomedical Prevention Trials with Youth: Lessons from Chicago's Project PrEPare.

Hosek SG, Green KR, Siberry G, Lally M, Balthazar C, Serrano PA, Kapogiannis B; The Adolescent Medicine Trials Network for HIV/AIDS Interventions.

J HIV AIDS Soc Serv. 2013;12(3-4). doi: 10.1080/15381501.2013.773575.

Supplemental Content

Support Center